Three years of follow-up of bone marrow-augmented organ transplant recipients: the impact on donor-specific immune modulation.
Zeevi
A
A
Thomas E. Starzl Pittsburgh Transplantation Institute, University of Pittsburgh Medical Center, Pennsylvania 15261, USA.
Pavlick
M
M
Banas
R
R
Bentlejewski
C
C
Spichty
K
K
Rao
A S
AS
Fontes
P
P
Iyengar
A
A
Shapiro
R
R
Dodson
F
F
Jordan
M
M
Pham
S
S
Keenan
R
R
Griffith
B
B
Corry
R
R
Egidi
F
F
Fung
J J
JJ
Starzl
T E
TE
D016026:Bone Marrow Transplantation; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology; D016027:Heart Transplantation / Q000276:immunology; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016381:Islets of Langerhans Transplantation / Q000276:immunology; D016030:Kidney Transplantation / Q000276:immunology; D016031:Liver Transplantation / Q000276:immunology; D016040:Lung Transplantation / Q000276:immunology; D008213:Lymphocyte Activation; D007959:Lymphocyte Culture Test, Mixed; D016035:Pancreas Transplantation / Q000276:immunology; D013997:Time Factors; D014019:Tissue Donors; D018183:Transplantation Chimera; D014181:Transplantation Immunology; D014184:Transplantation, Homologous / Q000276:immunology*